GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.95 $2.71 Friday, 19th Apr 2024 CANF stock ended at $1.98. This is 0.508% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 3.57% from a day low at $1.96 to a day high of $2.03.
90 days $1.92 $2.71
52 weeks $1.68 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
2023-10-19 $2.17 $2.17 $2.10 $2.10 1 889
2023-10-18 $2.22 $2.23 $2.13 $2.16 5 713
2023-10-17 $2.26 $2.29 $2.26 $2.29 761
2023-10-16 $2.30 $2.30 $2.19 $2.30 3 808
2023-10-13 $2.26 $2.28 $2.17 $2.28 1 652
2023-10-12 $2.24 $2.32 $2.24 $2.28 3 076
2023-10-11 $2.33 $2.39 $2.31 $2.34 2 801
2023-10-10 $2.27 $2.41 $2.20 $2.41 21 054
2023-10-09 $2.35 $2.36 $2.16 $2.16 16 226
2023-10-06 $2.39 $2.44 $2.39 $2.44 3 507
2023-10-05 $2.39 $2.39 $2.39 $2.39 771
2023-10-04 $2.50 $2.50 $2.42 $2.43 1 026
2023-10-03 $2.46 $2.62 $2.40 $2.42 6 004
2023-10-02 $2.60 $2.58 $2.49 $2.49 4 495
2023-09-29 $2.47 $2.69 $2.47 $2.65 2 735
2023-09-28 $2.59 $2.59 $2.49 $2.51 1 526
2023-09-27 $2.74 $2.79 $2.48 $2.50 53 877
2023-09-26 $2.53 $2.62 $2.48 $2.59 3 026
2023-09-25 $2.45 $2.50 $2.38 $2.49 9 559
2023-09-22 $2.56 $2.62 $2.52 $2.53 8 280
2023-09-21 $2.70 $2.70 $2.70 $2.70 2 016
2023-09-20 $2.65 $2.68 $2.65 $2.67 732
2023-09-19 $2.69 $2.68 $2.54 $2.65 9 832
2023-09-18 $2.69 $2.71 $2.63 $2.64 13 504
2023-09-15 $2.76 $2.79 $2.66 $2.66 4 958
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT